Academic literature on the topic 'Jak2-Stat3'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Jak2-Stat3.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Jak2-Stat3"
Zhou, Zehua, Ying Chen, Wenmin Dong, Rui An, Kun Liang, and Xinhong Wang. "Da Cheng Qi Decoction Alleviates Cerulein-Stimulated AR42J Pancreatic Acinar Cell Injury via the JAK2/STAT3 Signaling Pathway." Evidence-Based Complementary and Alternative Medicine 2021 (April 9, 2021): 1–13. http://dx.doi.org/10.1155/2021/6657036.
Full textJin, Wenyin, and Yinfeng Shen. "Da-Cheng-Qi Decoction Alleviates Intestinal Injury in Rats with Severe Acute Pancreatitis by Inhibiting the JAK2-STAT3 Signaling Pathway." Evidence-Based Complementary and Alternative Medicine 2019 (August 14, 2019): 1–12. http://dx.doi.org/10.1155/2019/3909468.
Full textHofmann, Hans-Dieter, and Matthias Kirsch. "JAK2-STAT3 signaling." JAK-STAT 1, no. 3 (2012): 191–93. http://dx.doi.org/10.4161/jkst.20446.
Full textKim, Hyunkyung, Dongha Kim, Seon Ah Choi, et al. "KDM3A histone demethylase functions as an essential factor for activation of JAK2−STAT3 signaling pathway." Proceedings of the National Academy of Sciences 115, no. 46 (2018): 11766–71. http://dx.doi.org/10.1073/pnas.1805662115.
Full textBouaouiche, Sarra, Silvia Ghione, Randa Sghaier, et al. "Nitric Oxide-Releasing Drug Glyceryl Trinitrate Targets JAK2/STAT3 Signaling, Migration and Invasion of Triple-Negative Breast Cancer Cells." International Journal of Molecular Sciences 22, no. 16 (2021): 8449. http://dx.doi.org/10.3390/ijms22168449.
Full textBarber, Ruth, Jenny Zobel, Daniel Beck, et al. "JAK2 Is a Direct BCL6 Target Gene: Implications for Therapy in Diffuse Large B-Cell Lymphoma." Blood 124, no. 21 (2014): 3112. http://dx.doi.org/10.1182/blood.v124.21.3112.3112.
Full textLi, Yun-Qing. "Down-Regulation of Insulin Signaling Is Involved in Painful Diabetic Neuropathy in Type 2 Diabetes." Pain Physician 2;16, no. 2;3 (2013): E71—E83. http://dx.doi.org/10.36076/ppj.2013/16/e71.
Full textLei, Bo, Ju Bai, Wanggang Zhang, et al. "Acute Monocytic Leukemia Associated Antigen MLAA-34 up-Regulates JAK2/STAT3 Expression and JAK2/STAT3 Enhances MLAA-34 Activation in a Positive Feedback Loop." Blood 126, no. 23 (2015): 1393. http://dx.doi.org/10.1182/blood.v126.23.1393.1393.
Full textZhang, Xuekang, Jun Zhou, Qian Hu, et al. "The Role of Janus Kinase/Signal Transducer and Activator of Transcription Signalling on Preventing Intestinal Ischemia/Reperfusion Injury with Dexmedetomidine." Journal of Nanoscience and Nanotechnology 20, no. 5 (2020): 3295–302. http://dx.doi.org/10.1166/jnn.2020.16416.
Full textLiu, Fa-Yu, Jawad Safdar, Zhen-Ning Li, et al. "CCR7 Regulates Cell Migration and Invasion through JAK2/STAT3 in Metastatic Squamous Cell Carcinoma of the Head and Neck." BioMed Research International 2014 (2014): 1–11. http://dx.doi.org/10.1155/2014/415375.
Full textDissertations / Theses on the topic "Jak2-Stat3"
Wang, Kepeng. "The involvement of JAK2/STAT2/STAT3 in myogenic differentiation /." View abstract or full-text, 2008. http://library.ust.hk/cgi/db/thesis.pl?BICH%202008%20WANGK.
Full textStudd, James. "The role of JAK2, STAT3 and ERBB2 in ovarian cancer." Thesis, Imperial College London, 2013. http://hdl.handle.net/10044/1/24443.
Full textPoulot, Yiannis. "Hétérogénéité et régulation des astrocytes dans la maladie d'Alzheimer : vers des interventions ciblées sur les voies JAK2-STAT3 et NF-kB." Electronic Thesis or Diss., université Paris-Saclay, 2024. http://www.theses.fr/2024UPASL060.
Full textHernández, Ribes Gracia. "ESTUDIO DE LA RUTA CELULAR JAK2/STAT3 COMO POTENCIAL INHIBIDOR EN EL MODELO DE FIBROSIS PULMONAR." Doctoral thesis, Universitat Politècnica de València, 2016. http://hdl.handle.net/10251/64087.
Full textJark, Paulo César [UNESP]. "Estudo da via jak2/stat3 e de seus inibidores em linfomas multicêntricos difusos de grandes células B caninos." Universidade Estadual Paulista (UNESP), 2016. http://hdl.handle.net/11449/146685.
Full textJark, Paulo César. "Estudo da via jak2/stat3 e de seus inibidores em linfomas multicêntricos difusos de grandes células B caninos /." Jaboticabal, 2016. http://hdl.handle.net/11449/146685.
Full textBen, Haim Lucile. "Modulation of the JAK2/STAT3 pathway in vivo : understanding reactive astrocyte functional features and contribution to neurodegenerative diseases." Thesis, Paris 6, 2014. http://www.theses.fr/2014PA066534/document.
Full textYerabolu, Naga Dinesh Reddy [Verfasser]. "Inhibition of the JAK2-STAT3 pathway using ruxolitinib as a therapeutic option for pulmonary hypertension / Naga Dinesh Reddy Yerabolu." Gießen : Universitätsbibliothek, 2020. http://d-nb.info/1223462145/34.
Full textCeyzériat, Kelly. "Modulation de la réactivité astrocytaire par ciblage de la voie JAK2-STAT3 : conséquences dans des modèles murins de la maladie d’Alzheimer." Thesis, Université Paris-Saclay (ComUE), 2017. http://www.theses.fr/2017SACLS556/document.
Full textEtter, Jonathan Parker. "Development of Inhibitors in the IL-6/GP130/JAK/STAT Pathway as Therapeutic Agents." The Ohio State University, 2013. http://rave.ohiolink.edu/etdc/view?acc_num=osu1376525461.
Full textBook chapters on the topic "Jak2-Stat3"
Wu, Ruifan, and Xinxia Wang. "SOCS3/JAK2/STAT3 pathway in iPSCs." In Molecular Players in iPSC Technology. Elsevier, 2022. http://dx.doi.org/10.1016/b978-0-323-90059-1.00009-9.
Full textDemir Çetinkaya, Büşra. "Targeting the SH2 Domain of STAT3 Proteins in Breast Cancer Treatment." In Current Researches in Health Sciences-II. Özgür Yayınları, 2023. http://dx.doi.org/10.58830/ozgur.pub128.c630.
Full textNawwaf Al-Harithy, Rowyda. "Adipocytokines: Are They the Theory of Cancer Progression?" In Tumor Angiogenesis [Working Title]. IntechOpen, 2022. http://dx.doi.org/10.5772/intechopen.104581.
Full textCentonze, Giorgia, Jennifer Chapelle, Costanza Angelini, et al. "The Scaffold Protein p140Cap as a Molecular Hub for Limiting Cancer Progression: A New Paradigm in Neuroblastoma." In Pheochromocytoma, Paraganglioma and Neuroblastoma. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.96383.
Full textLi, Xiao-Juan, Qing-Yu Ma, You-Ming Jiang, et al. "Xiaoyaosan Exerts Anxiolytic-like Effects by Down-regulating the TNF-α/JAK2-STAT3 Pathway in the Rat Hippocampus." In Insights into the Prevention and Treatment of Depression with Famous TCM Prescription Xiaoyaosan. B P International (a part of SCIENCEDOMAIN International), 2023. http://dx.doi.org/10.9734/bpi/mono/978-81-19315-94-9/ch13.
Full textConference papers on the topic "Jak2-Stat3"
Gritsina, Galina, Fang Xiao, Shane W. O'Brien, et al. "Abstract 1113: Targeting the JAK2/STAT3 pathway in ovarian cancer." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-1113.
Full textOvermoyer, BA, V. Almendro, S. Shu, et al. "Abstract P4-06-01: JAK2/STAT3 activity in inflammatory breast cancer supports the investigation of JAK2 therapeutic targeting." In Abstracts: Thirty-Fifth Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 4‐8, 2012; San Antonio, TX. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/0008-5472.sabcs12-p4-06-01.
Full textBallester, Beatriz, Javier Milara, Anselm Morell, et al. "Role of JAK2/STAT3 pathway in vascular function of pulmonary fibrosis patients." In Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa4902.
Full textChou, JC, PS Wang, SW Wang, and H. Lin. "PO-183 Prolactin activation of JAK2/STAT3 signalling pathway through GHR in NSCLC." In Abstracts of the 25th Biennial Congress of the European Association for Cancer Research, Amsterdam, The Netherlands, 30 June – 3 July 2018. BMJ Publishing Group Ltd, 2018. http://dx.doi.org/10.1136/esmoopen-2018-eacr25.704.
Full textJhaveri, K., E. Teplinsky, R. Arzu, et al. "Abstract PD5-6: Sustained hyperactivated mTOR & JAK2/STAT3 pathways in inflammatory breast cancer (IBC): Evidence for mTOR plus JAK2 therapeutic targeting." In Abstracts: Thirty-Sixth Annual CTRC-AACR San Antonio Breast Cancer Symposium - Dec 10-14, 2013; San Antonio, TX. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/0008-5472.sabcs13-pd5-6.
Full textHarada, Daijiro, Daijiro Harada, Nagio Takigawa, et al. "Abstract 717: JAK2/STAT3 induces erlotinib-resistance in lung cancer cells harboring EGFR-activating mutations." In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-717.
Full textSu, Wen-Pin, Ya-Chin Lo, Chien-Chung Lin, Helen H. W. Chen, Wu-Wei Lai, and Wu-Chou Su. "Abstract 1636: Anticancer drug-induced Jak2/Stat3 activation confers a survival advantage in lung cancer cells." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-1636.
Full textNam, Sangkil, Jun Xie, Angela Perkins, et al. "Abstract 864: Novel synthetic berbamine derivatives inhibit Jak2/Stat3 signaling and induce apoptosis of human melanoma cells." In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-864.
Full textJia, Zhenxian, Zhi Zhang, Ze Li, et al. "Abstract 4051: Anlotinib inhibits the progress of colorectal cancer cells by antagonizing glycolysis & JAK2-STAT3 signaling." In Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-4051.
Full textNagathihalli, Nagaraj, Yugandhar Beesetty, Michelle Reyzer, Chanjuan Shi, Richard Caprioli, and Nipun Merchant. "Abstract B32: JAK2 inhibition blocks STAT3 signaling and enhances drug delivery and therapeutic response in pancreatic cancer." In Abstracts: AACR Special Conference on Pancreatic Cancer: Progress and Challenges; June 18-21, 2012; Lake Tahoe, NV. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.panca2012-b32.
Full text